Seock‐Ah Im
Impact in
- Oncology top 0.01%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 492
- HER2/EGFR in Cancer Research 175
- Cancer Treatment and Pharmacology 124
- Colorectal Cancer Treatments and Studies 70
- Cancer Immunotherapy and Biomarkers 49
- Cancer Research 164
- Breast Cancer Treatment Studies 123
- Co-authors
- Yung‐Jue BangDo‐Youn OhSae‐Won HanSherene LoiHope S. RugoNorikazu MasudaTae‐You KimHiroji Iwata
- Journals
- Journal of Clinical Oncology (139 papers)Cancer Research (51 papers)Cancer Research and Treatment (40 papers)Breast Cancer Research and Treatment (19 papers)Annals of Oncology (18 papers)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Seock‐Ah Im
644 papers receiving 32.4k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 23.9k
- Cancer Research 9.0k
- Pulmonary and Respiratory Medicine 14.0k
- Genetics 2.5k
- Radiology, Nuclear Medicine and Imaging 4.1k
Countries citing papers authored by Seock‐Ah Im
This map shows the geographic impact of Seock‐Ah Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seock‐Ah Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seock‐Ah Im more than expected).
Fields of papers citing papers by Seock‐Ah Im
This network shows the impact of papers produced by Seock‐Ah Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seock‐Ah Im. The network helps show where Seock‐Ah Im may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Seock‐Ah Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 23 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 33 | |
| 7 | 2022 | 2 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 67 | |
| 10 | 2017 | 105 | |
| 11 | 2017 | 68 | |
| 12 | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Hit paper breakdown → | 2017 | 2156 |
| 13 | 2016 | 9 | |
| 14 | 2015 | 52 | |
| 15 | 2013 | 109 | |
| 16 | 2013 | 54 | |
| 17 | 2011 | 58 | |
| 18 | 2009 | 62 | |
| 19 | 2008 | 61 | |
| 20 | 2006 | 196 |
About Seock‐Ah Im
Seock‐Ah Im is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Gastroenterology and Pathology and Forensic Medicine, having authored 661 papers that have together received 32.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (175 papers), Advanced Breast Cancer Therapies (164 papers), Cancer Treatment and Pharmacology (124 papers), Breast Cancer Treatment Studies (123 papers), Colorectal Cancer Treatments and Studies (70 papers), Gastric Cancer Management and Outcomes (59 papers), Lung Cancer Treatments and Mutations (51 papers) and Cancer Immunotherapy and Biomarkers (49 papers). The work is most often cited by research in Oncology (23.9k citations), Cancer Research (9.0k citations), Pulmonary and Respiratory Medicine (14.0k citations), Genetics (2.5k citations) and Radiology, Nuclear Medicine and Imaging (4.1k citations). Seock‐Ah Im has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Yung‐Jue Bang, Do‐Youn Oh, Sae‐Won Han, Sherene Loi, Hope S. Rugo, Norikazu Masuda, Tae‐You Kim, Hiroji Iwata, Nadia Harbeck and Véronique Dièras. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Research and Treatment, Breast Cancer Research and Treatment and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.